PCI Biotech Holding ASA (OSL:PCIB) Total Assets : kr31.22 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Total Assets?

PCI Biotech Holding ASA's Total Assets for the quarter that ended in Dec. 2024 was kr31.22 Mil.

During the past 12 months, PCI Biotech Holding ASA's average Total Assets Growth Rate was 39.10% per year. During the past 3 years, the average Total Assets Growth Rate was -39.90% per year. During the past 5 years, the average Total Assets Growth Rate was -34.20% per year. During the past 10 years, the average Total Assets Growth Rate was -1.70% per year.

During the past 13 years, PCI Biotech Holding ASA's highest 3-Year average Total Assets Growth Rate was 38.60%. The lowest was -47.10%. And the median was 8.70%.

Total Assets is connected with ROA %. PCI Biotech Holding ASA's annualized ROA % for the quarter that ended in Dec. 2024 was -52.54%. Total Assets is also linked to Revenue through Asset Turnover. PCI Biotech Holding ASA's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

PCI Biotech Holding ASA Total Assets Historical Data

The historical data trend for PCI Biotech Holding ASA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Total Assets Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

209.12

135.98

63.48

44.05

31.22

PCI Biotech Holding ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Assets	Get a 7-Day Free Trial															63.48	52.52	44.05	37.41	31.22

PCI Biotech Holding ASA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PCI Biotech Holding ASA's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	23.453	+	7.762
	=	31.22

PCI Biotech Holding ASA's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	23.453	+	7.762
	=	31.22

PCI Biotech Holding ASA (OSL:PCIB) Total Assets Explanation

Total Assets is connected with ROA %.

PCI Biotech Holding ASA's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-18.03	/	( (37.412	+	31.215)	/ 2 )
	=	-18.03	/	34.3135
	=	-52.54 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PCI Biotech Holding ASA's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0	/	( (37.412	+	31.215)	/ 2 )
=	0	/	34.3135
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PCI Biotech Holding ASA Total Assets Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (OSL:PCIB) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

0JGL:UK

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.

PCI Biotech Holding ASA Headlines

No Headlines